{"title":"胆囊腺癌患者卡培他滨诱导的高甘油三酯血症","authors":"","doi":"10.33140/ijcrt.07.02.04","DOIUrl":null,"url":null,"abstract":"A 71-year-old man with gallbladder adenocarcinoma and no history of dyslipidemia presented with serum triglyceride level of 912 mg/dL after two months of starting Capecitabine. The lipemia due to elevated triglyceride also led to hemolysis, causing analytical interference to other biochemical tests and complete blood count.","PeriodicalId":310821,"journal":{"name":"International Journal of Cancer Research & Therapy","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Capecitabine-induced Hypertriglyceridemia in a Patient with Gallbladder Adenocarcinoma\",\"authors\":\"\",\"doi\":\"10.33140/ijcrt.07.02.04\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A 71-year-old man with gallbladder adenocarcinoma and no history of dyslipidemia presented with serum triglyceride level of 912 mg/dL after two months of starting Capecitabine. The lipemia due to elevated triglyceride also led to hemolysis, causing analytical interference to other biochemical tests and complete blood count.\",\"PeriodicalId\":310821,\"journal\":{\"name\":\"International Journal of Cancer Research & Therapy\",\"volume\":\"24 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Cancer Research & Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33140/ijcrt.07.02.04\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer Research & Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33140/ijcrt.07.02.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Capecitabine-induced Hypertriglyceridemia in a Patient with Gallbladder Adenocarcinoma
A 71-year-old man with gallbladder adenocarcinoma and no history of dyslipidemia presented with serum triglyceride level of 912 mg/dL after two months of starting Capecitabine. The lipemia due to elevated triglyceride also led to hemolysis, causing analytical interference to other biochemical tests and complete blood count.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
